SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001962738-24-000018
Filing Date
2024-05-03
Accepted
2024-05-03 08:59:18
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3 tmb-20240503xf3.htm F-3 342929
2 EX-5.1 tmb-20240503xex5d1.htm EX-5.1 78107
3 EX-23.1 tmb-20240503xex23d1.htm EX-23.1 2378
4 EX-FILING FEES tmb-20240503xexfees.htm EX-FILING FEES 48855
5 GRAPHIC tmb-20240503xexfees001.jpg GRAPHIC 659
6 GRAPHIC tmb-20240503xf3001.jpg GRAPHIC 11684
7 GRAPHIC tmb-20240503xf3002.jpg GRAPHIC 30503
  Complete submission text file 0001962738-24-000018.txt   532982
Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-279096 | Film No.: 24910968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)